╌>

(Science Friday)U.S. sees first case of bacteria resistant to all antibiotics

  

Category:  News & Politics

Via:  flynavy1  •  10 years ago  •  10 comments

(Science Friday)U.S. sees first case of bacteria resistant to all antibiotics

U.S. health officials on Thursday reported the first case in the country of a patient with an infection resistant to all known antibiotics, and expressed grave concern that the superbug could pose serious danger for routine infections if it spreads.

"We risk being in a post-antibiotic world," said Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, referring to the urinary tract infection of a 49-year-old Pennsylvania woman who had not travelled within the prior five months.

The mcr-1 plasmid-borne colistin resistance gene has been found primarily in Escherichia coli, pictured.     REUTERS/Courtesy CDC

Frieden, speaking at a National Press Club luncheon in Washington, D.C., said the infection was not controlled even by colistin, an antibiotic that is reserved for use against "nightmare bacteria."

The infection was reported Thursday in a study appearing in Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology. It said the superbug itself had first been infected with a tiny piece of DNA called a plasmid, which passed along a gene called mcr-1 that confers resistance to colistin.

"(This) heralds the emergence of truly pan-drug resistant bacteria," said the study, which was conducted by the Walter Reed National Military Medical Center. "To the best of our knowledge, this is the first report of mcr-1 in the USA."

The patient visited a clinic on April 26 with symptoms of a urinary tract infection, according to the study, which did not describe her current condition. Authors of the study could not immediately be reached for comment.

The study said continued surveillance to determine the true frequency of the gene in the United States is critical.

"It is dangerous and we would assume it can be spread quickly, even in a hospital environment if it is not well contained," said Dr. Gail Cassell, a microbiologist and senior lecturer at Harvard Medical School.

But she said the potential speed of its spread will not be known until more is learned about how the Pennsylvania patient was infected, and how present the colistin-resistant superbug is in the United States and globally.

"MEDICINE CABINET IS EMPTY FOR SOME"

In the United States, antibiotic resistance has been blamed for at least 2 million illnesses and 23,000 deaths annually.

The mcr-1 gene was found last year in people and pigs in China, raising alarm.

The potential for the superbug to spread from animals to people is a major concern, Cassell said.

For now, Cassell said people can best protect themselves from it and from other bacteria resistant to antibiotics by thoroughly washing their hands, washing fruits and vegetables thoroughly and preparing foods appropriately.

Experts have warned since the 1990s that especially bad superbugs could be on the horizon, but few drugmakers have attempted to develop drugs against them.

Frieden said the need for new antibiotics is one of the more urgent health problems, as bugs become more and more resistant to current treatments. "The more we look at drug resistance, the more concerned we are," Frieden added. "The medicine cabinet is empty for some patients. It is the end of the road for antibiotics unless we act urgently."

Overprescribing of antibiotics by physicians and in hospitals and their extensive use in food livestock have contributed to the crisis. More than half of all hospitalized patients will get an antibiotic at some point during their stay. But studies have shown that 30 percent to 50 percent of antibiotics prescribed in hospitals are unnecessary or incorrect, contributing to antibiotic resistance.

Many drugmakers have been reluctant to spend the money needed to develop new antibiotics, preferring to use their resources on medicines for cancer and rare diseases that command very high prices and lead to much larger profits.

In January, dozens of drugmakers and diagnostic companies, including Pfizer ( PFE.N ), Merck & Co ( MRK.N ), Johnson & Johnson ( JNJ.N ) and GlaxoSmithKline ( GSK.L ), signed a declaration calling for new incentives from governments to support investment in development of medicines to fight drug-resistant superbugs.

http://www.reuters.com/article/us-health-superbug-idUSKCN0YH2KT


Tags

jrDiscussion - desc
[]
 
FLYNAVY1
Professor Quiet
link   seeder  FLYNAVY1    10 years ago

"They're here....!"

I doubt that our technology is going to be able to operate fast enough to keep ahead of this problem as nature is evolving faster than our technology.  The pendulum has been swinging in favor of humans for the last 200 years or so.  I'm betting Ma nature is going to thin out our herd quite a bit.  A 95% reduction in world population is quite possible.  All one has to do is go back and look at the 95%-98% death rates of Native Americans when exposed to smallpox and other bugs brought by the European settlers.  I know that smallpox is a virus, but we are still talking about the same form of immunity mechanism when looking at bacteria.

For those that don't know, the ability to reproduce at a fast rate is a benefit in being able to adapt to changes in ones environment.  Creatures like bacterium, insects, and even fast breeding mammals like mice can become "resistant" and multiply quickly in the new environment.  Humans with our slow rate of reproduction are at the other end of the scale.  

 
 
 
Randy
Sophomore Quiet
link   Randy    10 years ago

Many drugmakers have been reluctant to spend the money needed to develop new antibiotics, preferring to use their resources on medicines for cancer and rare diseases that command very high prices and lead to much larger profits.

They'll wait, until there is an epidemic and then "ride to the rescue" with a hugely expensive version of an antibiotic that they'll charge thousands of times the amount of money it cost them to develop it because they know people will have no other choice but to buy it. Then someone in India will make a generic that'll do the same thing and the drug companies market will collapse, after they've made billions off the suffering of others. It's like a version of that TV commercial "If you're a pharmaceutical company you fuck people over with the cost of a new drug. It's what you do."

 
 
 
FLYNAVY1
Professor Quiet
link   seeder  FLYNAVY1  replied to  Randy   10 years ago

I suspect you're right Randy....... They've done it before.

 
 
 
Randy
Sophomore Quiet
link   Randy  replied to  FLYNAVY1   10 years ago

I remember reading that if aspirin had been developed in the last 25 years, with all it can do to help prevent or treat heart problems, the drug companies would be charges $10 or more a tablet for it, when I used to scoop it (the powder) by the half gallon scoop from large cardboard drums into machines at the drug company I worked at for ten years, to be compressed into tens of thousands of tablets a minute for less then pennies a pill.

 
 
 
Dowser
Sophomore Silent
link   Dowser  replied to  Randy   10 years ago

At least, if you have a willow tree, you can make your own...  EGAD!

 
 
 
Buzz of the Orient
Professor Expert
link   Buzz of the Orient    10 years ago

Humanity will reap what it has sown. We have altered the environment so much that pollution and radiation are bound to cause mutations. The cockroaches will take over the Earth. If should be no surprise that this mutant bacteria will have developed in China, considering the extremity of the pollution.

 
 
 
FLYNAVY1
Professor Quiet
link   seeder  FLYNAVY1    10 years ago

Where you have high rates of population, either at the level of bacterium, or at the human level is where you always find the first mutations of an organism.  It then should come as no surprise that China or India would be where we first see something like this bacteria.

 
 
 
LynneA
Freshman Silent
link   LynneA  replied to  FLYNAVY1   10 years ago

Agreeing with the high population rates, chances are this woman is not ground zero.  As the identification of this bacterium is dispersed throughout the medical community it'll be interesting to see the worldwide numbers.

Like Zika, we're at the tip of the iceberg...again.

 
 
 
FLYNAVY1
Professor Quiet
link   seeder  FLYNAVY1  replied to  LynneA   10 years ago

Spot on Lynne.... as always!

 
 
 
Dowser
Sophomore Silent
link   Dowser  replied to  LynneA   10 years ago

Scary, to me!

What's next?

 
 

Who is online